Table IIA. Adverse events listed as serious.
| Serious Adverse Events | ||
|---|---|---|
| SAE Terms | HQK-1001 (n=20) N (%) |
Placebo (n=4) N (%) |
| Crisis | 5 (25) | 3 (75) |
| Anemia | 1 (5) | 0 |
| Catheter site infection | 1 (5) | 0 |
| Arthralgia | 1 (5) | 0 |
| Pain in extremity | 1 (5) | 0 |
| Serious Adverse Events | ||
|---|---|---|
| SAE Terms | HQK-1001 (n=20) N (%) |
Placebo (n=4) N (%) |
| Crisis | 5 (25) | 3 (75) |
| Anemia | 1 (5) | 0 |
| Catheter site infection | 1 (5) | 0 |
| Arthralgia | 1 (5) | 0 |
| Pain in extremity | 1 (5) | 0 |